Arterial hypertension features in the elderly and their correction

Aim. To study vasomotor endothelial function (EF) in the elderly patients with arterial hypertension (AH), during its pharmaceutical correction. Material and methods. In total, 66 individuals aged over 60 years, with isolated systolic and systole-diastolic AH (ISAH, SDAH) were examined. All patients...

Full description

Bibliographic Details
Main Authors: L. I. Katelnitskaya, L. A. Khaisheva, S. A. Pleskachev
Format: Article
Language:Russian
Published: «SILICEA-POLIGRAF» LLC 2006-12-01
Series:Кардиоваскулярная терапия и профилактика
Subjects:
Online Access:https://cardiovascular.elpub.ru/jour/article/view/1399
_version_ 1797882717451321344
author L. I. Katelnitskaya
L. A. Khaisheva
S. A. Pleskachev
author_facet L. I. Katelnitskaya
L. A. Khaisheva
S. A. Pleskachev
author_sort L. I. Katelnitskaya
collection DOAJ
description Aim. To study vasomotor endothelial function (EF) in the elderly patients with arterial hypertension (AH), during its pharmaceutical correction. Material and methods. In total, 66 individuals aged over 60 years, with isolated systolic and systole-diastolic AH (ISAH, SDAH) were examined. All patients underwent 24-hour blood pressure monitoring (BMP), ultrasound assessment of EF and intima-media thickness (IMT), endotelin-1 level (ET-1) measurement, and lipid profile assessment. All participants received Nifecard® XL (Lek, Slovenia), for 6 months. Results. In ISAH patients, endothelial reaction to reactive hyperemia was significantly weaker than that in SDAH participants. AH patients had insufficient brachial artery vasodilatation in nitroglycerin test, as well as increased ET-1 levels. Maximal ET-1 levels were registered in SDAH individuals. After six-month Nifecard® ХL treatment, vascular EF substantially improved. According to 24-hour BPM data, BP circadian rhythm disturbances were quite common, being observed in 80% of ISAH patients, and 44.4% of SDAH subjects. During 6-month therapy, Nifecard® ХL demonstrated high antihypertensive activity: BP circadian rhythm normalized, number of patients with normal circadian rhythms doubled, and number of patients with unsatisfactory nighttime BP decrease, or nighttime AH, decreased. Conclusion: EF normalization and target BP level achievement are the main tasks of AH treatment. Long-acting, extended-release calcium antagonists are effective in the elderly patients.
first_indexed 2024-04-10T03:40:19Z
format Article
id doaj.art-1733421d0eb5433280db97d9a40ddd19
institution Directory Open Access Journal
issn 1728-8800
2619-0125
language Russian
last_indexed 2024-04-10T03:40:19Z
publishDate 2006-12-01
publisher «SILICEA-POLIGRAF» LLC
record_format Article
series Кардиоваскулярная терапия и профилактика
spelling doaj.art-1733421d0eb5433280db97d9a40ddd192023-03-13T07:23:13Zrus«SILICEA-POLIGRAF» LLCКардиоваскулярная терапия и профилактика1728-88002619-01252006-12-015617221109Arterial hypertension features in the elderly and their correctionL. I. Katelnitskaya0L. A. Khaisheva1S. A. Pleskachev2Государственный медицинский университет на базе КБ № 1 ЮМЦ. Ростов-на-ДонуГосударственный медицинский университет на базе КБ № 1 ЮМЦ. Ростов-на-ДонуГосударственный медицинский университет на базе КБ № 1 ЮМЦ. Ростов-на-ДонуAim. To study vasomotor endothelial function (EF) in the elderly patients with arterial hypertension (AH), during its pharmaceutical correction. Material and methods. In total, 66 individuals aged over 60 years, with isolated systolic and systole-diastolic AH (ISAH, SDAH) were examined. All patients underwent 24-hour blood pressure monitoring (BMP), ultrasound assessment of EF and intima-media thickness (IMT), endotelin-1 level (ET-1) measurement, and lipid profile assessment. All participants received Nifecard® XL (Lek, Slovenia), for 6 months. Results. In ISAH patients, endothelial reaction to reactive hyperemia was significantly weaker than that in SDAH participants. AH patients had insufficient brachial artery vasodilatation in nitroglycerin test, as well as increased ET-1 levels. Maximal ET-1 levels were registered in SDAH individuals. After six-month Nifecard® ХL treatment, vascular EF substantially improved. According to 24-hour BPM data, BP circadian rhythm disturbances were quite common, being observed in 80% of ISAH patients, and 44.4% of SDAH subjects. During 6-month therapy, Nifecard® ХL demonstrated high antihypertensive activity: BP circadian rhythm normalized, number of patients with normal circadian rhythms doubled, and number of patients with unsatisfactory nighttime BP decrease, or nighttime AH, decreased. Conclusion: EF normalization and target BP level achievement are the main tasks of AH treatment. Long-acting, extended-release calcium antagonists are effective in the elderly patients.https://cardiovascular.elpub.ru/jour/article/view/1399функция эндотелияартериальная гипертонияпожилые
spellingShingle L. I. Katelnitskaya
L. A. Khaisheva
S. A. Pleskachev
Arterial hypertension features in the elderly and their correction
Кардиоваскулярная терапия и профилактика
функция эндотелия
артериальная гипертония
пожилые
title Arterial hypertension features in the elderly and their correction
title_full Arterial hypertension features in the elderly and their correction
title_fullStr Arterial hypertension features in the elderly and their correction
title_full_unstemmed Arterial hypertension features in the elderly and their correction
title_short Arterial hypertension features in the elderly and their correction
title_sort arterial hypertension features in the elderly and their correction
topic функция эндотелия
артериальная гипертония
пожилые
url https://cardiovascular.elpub.ru/jour/article/view/1399
work_keys_str_mv AT likatelnitskaya arterialhypertensionfeaturesintheelderlyandtheircorrection
AT lakhaisheva arterialhypertensionfeaturesintheelderlyandtheircorrection
AT sapleskachev arterialhypertensionfeaturesintheelderlyandtheircorrection